Apeloa Pharmaceutical Co.,Ltd

SZSE:000739.SZ

15.68 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012201120102009200820072006200520042003200220012000199919981997199619951994
Revenue 11,418.07310,544.9058,942.6187,879.6737,210.7116,376.4015,551.7634,772.1894,337.9414,232.763,899.7653,480.0881,534.4761,520.9851,367.8541,250.4461,041.521,148.5561,035.416830.516770.251659.335141.838178.823225.645418.09367.697368.68344.315331.164
Cost of Revenue 8,686.5578,024.2296,569.3465,676.6324,876.5784,340.533,839.8683,444.2943,149.7353,131.3553,016.9932,672.7311,236.8931,201.1251,068.9271,011.511845.828915.425833.385671.378611.25511.017130.745156.572187.101366.308313.118313.64294.64288.034
Gross Profit 2,731.5152,520.6762,373.2722,203.0412,334.1332,035.8711,711.8961,327.8951,188.2061,101.406882.772807.357297.583319.86298.927238.935195.692233.13202.031159.138159.002148.31811.09322.25138.54551.78154.57955.04149.67543.13
Gross Profit Ratio 0.2390.2390.2650.280.3240.3190.3080.2780.2740.260.2260.2320.1940.210.2190.1910.1880.2030.1950.1920.2060.2250.0780.1240.1710.1240.1480.1490.1440.13
Reseach & Development Expenses 540.569532.92446.219350.055359.893269.651259.176210.14183.236129.98398.50597.81849.87947.9540000000000000000
General & Administrative Expenses 77.5774.701123.906110.659143.49162.367159.414112.998132.904104.32877.93374.65234.24632.308152.649124.51397.68295.38273.74855.01257.25948.71219.02320.45322.79617.85612.64516.78215.8714.533
Selling & Marketing Expenses 658.423535.263452.527573.624835.338808.935515.013316.843242.66222.731182.547167.59571.33170.46558.47544.34330.07138.68448.96133.67931.85628.25512.8814.90515.80415.88315.44917.25716.23916.116
SG&A 1,066.822609.965576.433684.284978.828971.302674.427429.842375.565327.058260.48242.247105.577102.772211.124168.856127.753134.066122.70988.6989.11676.96831.90435.35838.633.73928.09534.03932.10930.65
Other Expenses -42.004313.22264.686216.903269.633-30.8283.92774.41666.76328.74222.6827.08816.1447.2173.8931.2166.572.5171.6561.5410.712.437.45216.68113.89219.7757.0915.7656.3954.128
Operating Expenses 1,649.3951,456.1051,287.3381,251.2421,608.3541,516.6061,255.7431,015.513913.383744.944634.871550.139252.663250.393217.995173.529132.64139.13125.20790.1990.54578.46532.66835.9639.80935.41229.38135.76633.48631.33
Operating Income 1,082.1211,011.6231,119.355969.706644.154490.539335.693273.636202.342343.065185.482143.552-11.39121.17334.56626.67125.35861.3652.92248.64650.7249.89-25.0484.8888.88530.60331.1119.96218.33814.099
Operating Income Ratio 0.0950.0960.1250.1230.0890.0770.060.0570.0470.0810.0480.041-0.0070.0140.0250.0210.0240.0530.0510.0590.0660.076-0.1770.0270.0390.0730.0850.0540.0530.043
Total Other Income Expenses Net 119.2570.443-5.275-8.553-10.428-57.068-116.53422.945-27.81720.746-42.158-88.939-41.075-42.122-43.162-37.975-31.792-35.945-28.367-21.718-19.729-19.883-11.9084.188-1.7862.3933.676-5.09-4.48-2.168
Income Before Tax 1,201.3781,012.0651,114.08961.153633.726462.197339.619335.327247.006377.207205.742168.283.84527.34537.7727.4331.26160.96651.51848.70850.07951.145-25.5396.0249.86434.5733.53819.95618.22113.93
Income Before Tax Ratio 0.1050.0960.1250.1220.0880.0720.0610.070.0570.0890.0530.0480.0030.0180.0280.0220.030.0530.050.0590.0650.078-0.180.0340.0440.0830.0910.0540.0530.042
Income Tax Expense 149.33722.894158.53144.42380.32591.6383.02772.4338.77650.4944.75733.7290.6157.3334.9071.4263.4369.8355.41611.19113.39217.1620.505-1.4922.0028.51710.5365.7335.2353.369
Net Income 1,055.341989.174955.55816.73553.401370.567256.592262.897208.23322.164167.359137.1338.24923.78934.08529.05930.44351.95743.75535.62634.19231.588-25.8727.4787.62925.73323.00214.22212.98710.561
Net Income Ratio 0.0920.0940.1070.1040.0770.0580.0460.0550.0480.0760.0430.0390.0050.0160.0250.0230.0290.0450.0420.0430.0440.048-0.1820.0420.0340.0620.0630.0390.0380.032
EPS 0.90.850.810.690.470.310.220.230.180.30.210.280.0780.0350.0510.0440.0480.0940.0620.050.0480.045-0.041-0.0050.0110.0060.0350.0220.0210.017
EPS Diluted 0.90.850.810.690.470.310.220.230.180.30.210.280.0780.0350.0510.0440.0480.0940.0620.050.0480.045-0.041-0.0050.0110.0060.0350.0220.0210.017
EBITDA 1,641.091,559.6571,579.6711,308.5731,051.712870.877759.281754.737649.948735.983541.223492.61161.891167.349170.019136.21122.864147.73119.637104.297.08894.856-12.82512.2274.73320.85125.19919.27516.18911.801
EBITDA Ratio 0.1440.1480.1770.1660.1460.1370.1370.1580.150.1740.1390.1420.1060.110.1240.1090.1180.1290.1160.1250.1260.144-0.090.0680.0210.050.0690.0520.0470.036